Abstract：Objective: To study the correlation between serum microRNA-122 (miR-122) and miR-130a and occult hepatitis B (OBI), and to explore their diagnostic value for OBI. Methods: 60 patients with OBI (OBI group), 60 carriers of inactive HBsAg (ASC) (ASC group), 60 patients with chronic hepatitis B (CHB) (CHB group) and 60 suspicious patients (control group) were selected. The expression of serum miR-122 and miR-130a was detected by real-time fluorescence quantitative method. Results: The relative expression level of serum miR-122 in OBI group was significantly lower than that in the other three groups (all P<0.05). However, the relative expression level of miR-130a was significantly higher than that in the three groups (all P<0.05). The relative expression level of serum miR-122 in OBI group, the control group, ASC group and CHB group increased in turn (all P<0.05), and the relative expression level of miR-130a in OBI group, CHB group, ASC group and control group decreased in turn (all P<0.05). The value of miR-130a/miR-122 in OBI group was significantly higher than that in the other three groups (all P<0.05). Pearson correlation analysis showed that the expression of serum miR-122 was negatively correlated with the expression of miR-130a in patients with OBI (r=0.421, P<0.05). ROC curve analysis showed that the areas under the curves of serum miR-122, miR-130a and miR-130a/miR-122 value for differentiating patients with OBI and suspicious patients were 0.859 (95% CI: 0.762~0.955), 0.844 (95% CI: 0.739~0.950) and 0.945 (95% CI: 0.018~0.989), respectively. The areas under the curves for differentiating OBI and ASC were 0.942 (95% CI: 0.021~0.995), 0.813 (95% CI: 0.699~0.927) and 0.964 (95% CI: 0.012~0.997), respectively. The areas under the curves for differentiating OBI and CHB were 0.998 (95% CI: 0.000~1.000), 0.646 (95% CI: 0.503~0.789) and 0.993 (95% CI: 0.000~1.000), respectively. Conclusion: The decreased expression of serum miR-122 and the increased expression of miR-130a are associated with OBI, which is of important diagnostic value for OBI. The diagnostic value of miR-130a/miR-122 is higher than that of serum miR-122 and miR-130a alone.
徐兰锋, 王倩, 刘洪玲, 迟男男. 血清MicroRNA 122和MicroRNA-130a水平在隐匿性乙型肝炎病毒感染中的诊断价值初探[J]. 河北医学, 2020, 26(3): 366-369.
XU Lanfeng, WANG Qian, LIU Hongling, et al. Diagnostic Value of Serum MicroRNA 122 and Microrna-130a Levels in Occult Hepatitis B Virus Infection. HeBei Med, 2020, 26(3): 366-369.
[1] Xing T,Xu H,Yu W,et al.Expression profile and clinical significance of miRNAs at different stages of chronic hepatitis B virus infection.[J].Int J Clin Exp Med,2015,8(4):5611~5620. [2] 刘强,唐绮,余薇,等.HLA-DRB1基因与隐匿性乙型肝炎相关性的研究[J].中国输血杂志,2017,30(7):670~673. [3] Pollicino T,Squadrito G,Cerenzia G,et al.Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection[J].Gastroenterol,2004,126(1):102~110. [4] 吕雯婷,许思遥,樊毅,等.MicroRNA调控乙型脑炎病毒复制及发病机制的研究进展[J].病毒学报,2017,33(4):624~630. [5] 吕敏仪,范雪娇,孙茜,等.乙型肝炎病毒DNA复制水平与抗原血清标志物的相关性[J].实用医学杂志,2017,33(2):282~285. [6] 庄鹏,曾慧琼,王湘郴,等.miR-122在乙肝相关性肝癌发病机制中的作用[J].热带医学杂志,2015,15(6):724~727. [7] Huang J Y,Chou S F,Lee J W,et al.MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1αand PPARγ[J].RNA,2015,21(3):385~400. [8] 王贵强,王福生,成军,等.慢性乙型肝炎防治指南(2015更新版)[J].肝脏,2015,33(6):321~340. [9] Wang G,Dong F,Xu Z,et al.MicroRNA profile in HBV-induced infection and hepatocellular carcinoma[J].Bmc Cancer,2017,17(1):805~812. [10] Li C,Wang Y,Wang S,et al.Hepatitis B virus mRNA-Mediated miR-122 inhibition upregulates PTTG1-binding protein,which promotes hepatocellular carcinoma tumor growth and cell invasion[J].Virol,2013,87(4):2193~205. [11] Chen Y,Li L,Zhou Z,et al.A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection[J].Med Microbiol Immunol,2012,201(3):389~395.
2020, Vol. 26 
冀公网安备13080202000677号